DK2344167T3 - Inhibitorer af f18+-e. coli-binding - Google Patents

Inhibitorer af f18+-e. coli-binding

Info

Publication number
DK2344167T3
DK2344167T3 DK09752310.4T DK09752310T DK2344167T3 DK 2344167 T3 DK2344167 T3 DK 2344167T3 DK 09752310 T DK09752310 T DK 09752310T DK 2344167 T3 DK2344167 T3 DK 2344167T3
Authority
DK
Denmark
Prior art keywords
inhibitors
coli binding
coli
binding
Prior art date
Application number
DK09752310.4T
Other languages
English (en)
Inventor
Eric COX
Annelies Coddens
Susann Eva Teneberg
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Application granted granted Critical
Publication of DK2344167T3 publication Critical patent/DK2344167T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK09752310.4T 2008-10-01 2009-09-30 Inhibitorer af f18+-e. coli-binding DK2344167T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0817908.7A GB0817908D0 (en) 2008-10-01 2008-10-01 Blood group a/b/h determinant on type 1 core glycosphinglipids chain as recognition point for the fedf protein of f18-fimbriated enterotoxigenic
PCT/EP2009/062699 WO2010037785A2 (en) 2008-10-01 2009-09-30 Inhibitors of f18+ e coli binding

Publications (1)

Publication Number Publication Date
DK2344167T3 true DK2344167T3 (da) 2014-09-15

Family

ID=40019820

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09752310.4T DK2344167T3 (da) 2008-10-01 2009-09-30 Inhibitorer af f18+-e. coli-binding

Country Status (6)

Country Link
US (1) US8703722B2 (da)
EP (1) EP2344167B1 (da)
DK (1) DK2344167T3 (da)
ES (1) ES2499025T3 (da)
GB (1) GB0817908D0 (da)
WO (1) WO2010037785A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013062479A1 (en) * 2011-10-28 2013-05-02 Glycorex Transplantation Ab A method for extracorporeal elimination of one or more components from blood
CN109504643B (zh) * 2018-11-27 2022-06-10 扬州大学 整合四拷贝功能性f18菌毛操纵子基因的益生菌克隆株、构建方法及应用
WO2022189361A1 (en) 2021-03-08 2022-09-15 Universiteit Gent Conjugates including multiple saccharidic chains on a linear protein and uses in mammals feed
WO2024003222A1 (en) 2022-06-29 2024-01-04 Inbiose N.V. Fucosylated saccharide for use in the prevention or treatment of bacterial disease
WO2024003223A1 (en) 2022-06-29 2024-01-04 Inbiose N.V. Fucosylated saccharide for use in the prevention or treatment of parasitic disease
WO2024121153A1 (en) 2022-12-05 2024-06-13 Inbiose N.V. Use of a sialylated saccharide for maintaining or improving mobility in a healthy subject
WO2024121171A1 (en) 2022-12-05 2024-06-13 Inbiose N.V. Sialylated saccharide for use in the prevention or treatment of an inflammatory disease and/or autoimmune disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
DE60232077D1 (de) 2001-06-29 2009-06-04 Glykos Finland Oy Verwendung mindestens einer glycoinhibitor-substanz gegen infektionskrankheiten
US7767415B2 (en) 2001-09-25 2010-08-03 Velico Medical, Inc. Compositions and methods for modifying blood cell carbohydrates
WO2004002495A1 (en) * 2002-06-28 2004-01-08 Glykos Finland Oy Therapeutic compositions for use in prophylaxis or treatment of diarrheas
WO2005055944A2 (en) * 2003-12-05 2005-06-23 Cincinnati Children's Hospital Medical Center Oligosaccharide compositions and use thereof in the treatment of infection
FI20065800A0 (fi) 2006-12-13 2006-12-13 Glykos Finland Oy Polyvalentit biokonjugaatit
AU2008206887B9 (en) * 2007-01-18 2011-07-07 Glykos Finland Oy Novel specific cell binders
FI20095418A0 (fi) 2009-04-16 2009-04-16 Suomen Punainen Risti Veripalv Kryptinen subpopulaatio

Also Published As

Publication number Publication date
EP2344167A2 (en) 2011-07-20
WO2010037785A3 (en) 2010-06-03
US8703722B2 (en) 2014-04-22
WO2010037785A2 (en) 2010-04-08
US20110306574A1 (en) 2011-12-15
ES2499025T3 (es) 2014-09-26
GB0817908D0 (en) 2008-11-05
EP2344167B1 (en) 2014-07-02

Similar Documents

Publication Publication Date Title
CY2020023I1 (el) Αναστολεiς βητα-λακταμασων
CY2019009I1 (el) Αναστολεις πρωτεϊνικων κινασων
CY2017016I1 (el) Αναστολεις πρωτεασωματος
BRPI0908115A2 (pt) torneira
BRPI1010301A2 (pt) composição.
DK2086960T3 (da) Nye inhibitorer af glutaminylcyclase.
BRPI0919575A2 (pt) método, e, composição
DK2041138T3 (da) Pyrroltriazinkinase-inhibitorer
DK2024375T3 (da) Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere
DK2246336T3 (da) Fibroseinhibitor
BRPI0915047A2 (pt) Composição herbicida
BRPI0918564A2 (pt) inibidores
BRPI0823277A2 (pt) Composição, e , método
DK2245032T3 (da) Folater, sammensætninger og anvendelser deraf
DK2250401T3 (da) Aktuator
SMT201500157B (it) Pirazolilaminopiridine come inibitori di fak
DE102008038258B8 (de) Projektil
DK2280962T5 (da) Pyridazinonderivater
DK2141172T3 (da) Cyclopropylpolymerase inhibitorer
BRPI0918637A2 (pt) composição antimicrobiana.
BRPI0823238A2 (pt) Composição, e, método
BRPI0914584A2 (pt) Método, e, composição herbicida.
DK2066662T3 (da) Serinhydrolaseinhibitorer
DK2344167T3 (da) Inhibitorer af f18+-e. coli-binding
DE602006005232D1 (de) Konzentrierte Esterquat-zusammensetzung